Kura Oncology Q1 2026 Earnings Wider Loss as Clinical Progress Continues MNPR Q1 2026 Earnings Surprise EPS Beat in PreRevenue Biotech BWBBP Q1 2026 Earnings Preferred Stock EPS Slightly Misses Estimates Stock Declines Modestly DIOD Q1 2026 Earnings Strong EPS Surprise of 27 Drives Stock Higher ABCB Q1 2026 Earnings EPS Surpasses Estimates Amidst Stable Operations TRMD Q1 2026 Earnings EPS Surprises to the Upside Amid Cautious Market Sentiment